DCUSX Mutual Fund

DCUSX Mutual Fund

NAV$17.51
See how much of DCUSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$670M
Expense Ratio
0.66%
Dividend Yield (Current)
9.23%
Holdings
94
Inception Date
Apr 10, 2015
Fund Family
DWS
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+19.62%
1 Year+28.99%
3 Year+24.25%
5 Year+12.59%
10 Year+10.17%

Asset Allocation

Stocks: 99.64%
Cash: 0.36%
See how much of DCUSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
BMYBristol-Myers Squibb Co.3.39%
KHCKraft Heinz Co.3.26%
PFEPfizer Inc3.11%
MRKMerck & Company Inc3.05%
AAPLApple Inc2.88%
Top 10 Concentration: 27.50%Report Date: Aug 31, 2026
Download all 94 holdings for DCUSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
9.23%
Frequency
Annually
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

DCUSX Mutual Fund Overview

DCUSX Mutual Fund (DWS CROCI US Fund Class S) is managed by DWS with $669.5M in net assets. DCUSX expense ratio is 0.66%, holding 94 positions across sectors including Information Technology, Health Care, Financials. Inception date: 2015-04-10.

DCUSX performance shows a YTD return of 19.62%. The 1-year return is 28.99% and the 5-year return is 12.59%. DCUSX dividend yield stands at 9.23%, paid annually.

DCUSX top holdings include Bristol-Myers Squibb Co. (3.4%), Kraft Heinz Co. (3.3%), Pfizer Inc (3.1%), Merck & Company Inc (3.0%), Apple Inc (2.9%). Go to all DCUSX holdings, DCUSX sectors, or DCUSX dividends.

DCUSX can be compared against other funds. Use DCUSX overlap to find shared positions, or DCUSX vs another fund for a side-by-side view. DCUSX alternatives are available via the screener, along with tax-loss harvesting opportunities.